Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-049790

Chief Executive Officer sold 35,452 shares at an average $94.92 ($3,365,010)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BELANOFF JOSEPH K · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-31 Sale : show line 1 in the form 10b5-1 −35,102 $94.72 $3,324,861 2,982,335 I
2025-04-01 Sale : show line 2 in the form 10b5-1 −350 $114.71 $40,149 2,981,985 I
Open-market sales · 35,452 sh · avg $94.92 · $3,365,010
Loading xslF345X05/ownership.xml…